isuprel 1:5000 1mg/5ml injection
pfizer australia pty ltd - isoprenaline hydrochloride -
isuprel 1:5000 200microgram/1ml injection
pfizer australia pty ltd - isoprenaline hydrochloride -
isoprenaline hydrochloride
company liquidated m123 - isoprenaline hydrochloride - withdrawn form - 1 millilitre
isoprenaline hydrochloride
company liquidated m123 - isoprenaline hydrochloride - withdrawn form - 5 millilitre
isuprel 0.2 mg/ml inf. sol. (conc.) i.v. amp.
hospira benelux bv-srl - isoprenaline hydrochloride 0,2 mg/ml - concentrate for solution for infusion - 0,2 mg/ml - isoprenaline hydrochloride 0.2 mg/ml - isoprenaline
isoprenaline hydrochloride monico 0.2mg/1ml solution for injection
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for injection - isoprenaline hydrochloride 0.2 mg/ml - cardiac therapy
isoprenaline hydrochloride monico 0.2 mg/1 ml solution for injection
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for injection - isoprenaline hydrochloride 0.2 mg - cardiac therapy
duo-autohaler
3m health care limited - isoprenaline phenylephrine bitartrate -
medihaler-duo
3m health care limited - phenylephrine bitartrate isoprenaline hydrochloride -
isocipraline isoprenaline hydrochloride 1.0 mg/5 ml injection solution ampoule
cipla australia pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - isocipraline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).